You are here:
As a public-private partnership including civil society, the Vaccine Alliance plays a catalytic role providing funding to countries and demonstrates "added-value" by:
Gavi Strategy 2011-2015: Business plan
Gavi Strategy & Business Plan
Over the course of a decade, the weighted average price of pentavalent vaccine (DTP-hepB-Hib) dropped by 43% from US$ 3.56 per dose in 2003 to US$ 2.04 per dose in 2013, with a lowest-ever price of US$ 1.19 from one supplier in 2013.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here